galactose has been researched along with h 89 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raymond, MN; Robin, P; Rossignol, B | 1 |
| Barber, A; Barrenetxe, J; Gascón, S; Lostao, MP; Rodríguez-Yoldi, MJ; Sánchez, O | 1 |
| Mathupala, SP; Perdersen, PL; Rempel, A | 1 |
3 other study(ies) available for galactose and h 89
| Article | Year |
|---|---|
PKA inhibitor, H-89, affects the intracellular transit of regulated secretory proteins in rat lacrimal glands.
Topics: Animals; Calcimycin; Calcium; Carbachol; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Exocytosis; Galactose; Glycoproteins; Golgi Apparatus; In Vitro Techniques; Isoquinolines; Kinetics; Lacrimal Apparatus; Leucine; Male; Rats; Rats, Sprague-Dawley; Sulfonamides; Temperature | 1998 |
TNFα regulates sugar transporters in the human intestinal epithelial cell line Caco-2.
Topics: Benzophenanthridines; Biological Transport; Caco-2 Cells; Cell Line; Fructose; Galactose; Glucose Transporter Type 5; Humans; Inflammation; Intestinal Mucosa; Isoquinolines; Methylglucosides; Monosaccharide Transport Proteins; Protein Kinase Inhibitors; Sodium-Glucose Transporter 1; Sulfonamides; Tumor Necrosis Factor-alpha | 2013 |
Glucose catabolism in cancer cells: regulation of the Type II hexokinase promoter by glucose and cyclic AMP.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Bucladesine; Colforsin; Cyclic AMP; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Glucose; Hexokinase; Hexoses; Isoquinolines; Liver Neoplasms, Experimental; Mannoheptulose; Promoter Regions, Genetic; Rats; Signal Transduction; Sulfonamides; Transfection; Tumor Cells, Cultured | 1996 |